Wolfe Research reiterates Peerperform on Nebius Group stock By Investing.com

Nebius posted explosive Q1 2026 results, with revenue up 684% year-over-year to $399 million, ARR at $1.9 billion, and operating cash flow of $2.3 billion driven by upfront customer payments. The company raised fiscal 2026 capex guidance by $4.5 billion at the midpoint to a $20 billion-$25 billion range and increased its contracted power target to more than 4 gigawatts. Wolfe Research kept a Peerperform rating, while DA Davidson raised its price target to $250 from $200 after the earnings beat.

Analysis

NBIS is moving from a simple AI demand story into a capital-allocation credibility test. The key second-order effect is that prepayments and sold-out capacity reduce near-term funding stress, but they also mask how much of the current economics are timing-driven rather than fully recurring operating leverage; that makes the stock highly sensitive to any change in customer payment cadence or active-capacity conversion. In other words, the market is paying today for 2027 visibility, while the business still has to physically convert contracted power into cash flow at scale.

The biggest competitive implication is that capacity scarcity is now a pricing event across the broader AI infrastructure stack, not just a Nebius-specific one. If NBIS can continue to reprice GPU access and power commitments, peers with slower deployment or less pre-sold capacity should see pressure on deal terms, especially where customers are benchmarking against Nebius’s ability to secure power and monetize it early. But this also creates a reflexive risk: aggressive capex raises the bar for flawless execution, and any slippage in commissioning, grid interconnection, or datacenter buildout would compress the multiple quickly because the market is already capitalizing multiple years of growth.

The contrarian read is that the stock likely benefits from a “scarcity premium” that can persist for months, but not indefinitely if the company proves it can simply raise more capital and expand faster. If that becomes the dominant narrative, valuation should migrate from a scarcity/optionality framework toward a utility-like infrastructure framework, which is materially less forgiving. The trade is therefore less about whether demand is real and more about whether the market is overpaying for the speed and certainty of monetization.

Near term, the path is dominated by execution milestones, not macro. Over the next 1-3 quarters, the key catalyst is evidence that new capacity becomes active on schedule and that customer prepayments keep funding a meaningful share of the buildout; the key tail risk is that the market starts discounting 2027 demand before 2026 delivery capacity is proven. If that gap widens, the stock can de-rate sharply even with strong bookings intact.

Key Decisions for Investors

• Stay long NBIS only via defined-risk structures: buy 3-6 month call spreads rather than outright equity, targeting continuation of the scarcity premium while capping downside if capex or buildout execution disappoints.
• Pair trade: long NBIS / short a slower-moving AI infrastructure proxy with less near-term capacity visibility over the next 1-2 quarters, betting that the market pays up for pre-sold power and monetization speed.
• Hedge the name into any post-earnings strength by buying 2-3 month puts or put spreads; the stock’s multiple is highly exposed to any sign that contracted capacity is not converting to active revenue on schedule.
• If you want exposure to the theme without single-name execution risk, rotate part of the position into suppliers or infrastructure enablers with more diversified demand and less balance-sheet intensity; they benefit from the same capex cycle with lower binary risk.
• Set an execution checkpoint around the next two quarterlies: if active capacity additions lag the raised power targets, reduce exposure aggressively because the market is already pricing a near-perfect conversion path.